Efficacy & Safety of TD-1473 in Ulcerative Colitis

Clinical trial NCT03758443 · TERMINATED

Trial details

NCT number: NCT03758443
Sponsor: Theravance Biopharma
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Ulcerative Colitis (UC)

Start date: 2019-03-11
Primary completion: 2021-10-20
Enrollment: 239

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.